Detalles de la búsqueda
1.
Propensity score matched all comers population treated with ultra-thin strut bare metal and sirolimus-probucol coated drug-eluting stents of identical stent architecture.
Catheter Cardiovasc Interv
; 91(7): 1221-1228, 2018 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-28944613
2.
Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials.
Catheter Cardiovasc Interv
; 91(3): 387-395, 2018 02 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28471086
3.
Recurrent in-stent restenosis with total occlusion remedied with drug-eluting balloon angioplasty.
Int Heart J
; 52(1): 61-3, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21321471
4.
Asia Pacific TAVI registry (an APSIC initiative): initial report of early outcomes: Asia Pacific TAVI registry.
AsiaIntervention
; 7(1): 54-59, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34913003
5.
The REMEDEE trial: a randomized comparison of a combination sirolimus-eluting endothelial progenitor cell capture stent with a paclitaxel-eluting stent.
JACC Cardiovasc Interv
; 6(4): 334-43, 2013 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-23523459
6.
Updates in the management of Dyslipidaemia in the high and very high risk individual for CV risk reduction
The Medical Journal of Malaysia
; : 154-162, 2018.
Artículo
en Inglés
| WPRIM | ID: wpr-732558
7.
Acute coronary syndrome in the elderly: the Malaysian National Cardiovascular Disease Database-Acute Coronary Syndrome registry
Singapore medical journal
; : 191-197, 2016.
Artículo
en Inglés
| WPRIM | ID: wpr-276718
8.
Prevalence And Risk Factors Of Premature Coronary Artery Disease: A Comparative Cross-Sectional Study Between Two Time Frames In Malaysia
Malaysian Journal of Public Health Medicine
; : 157-166, 2015.
Artículo
en Inglés
| WPRIM | ID: wpr-626697
9.
Risk and timing of clinical events according to diabetic status of patients treated with everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting stent: 2-year results from a propensity score matched comparison of ABSORB EXTEND and SPIRIT trials
Catheter Cardiovasc Interv
; 91(3): 387-395, 2018. tab, graf
Artículo
en Inglés
| SES-SP, SESSP-IDPCPROD, SES-SP | ID: biblio-1061866
Resultados
1 -
9
de 9
1
Próxima >
>>